Devices and formulations for detecting, screening and monitoring levels of certain constituents in bodily fluids and method

• US 9,005,914 B2
• Filed: 03/15/2013
• Issued: 04/14/2015
• Est. Priority Date: 10/23/2010
• Status: Active Grant

• Current Assignee: Pop Test LLC
• Original Assignee: Pop Test LLC
• Inventors: Altschul, Randice Lisa, Rapkin, Myron, O'Brien, Rebecca
• Primary Examiner(s): Shen, Bin
• Application Number:
  US13/836,679
• Publication Number:
  US 20130203094A1
• Time in Patent Office: 760 Days
• Field of Search: 435/25
• US Class Current: 435/25
• CPC Class Codes: B01L 3/5082 Test tubes per se
• CPC Class Codes: G01N 21/78 producing a change of colour
• CPC Class Codes: G01N 33/52 Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements immunological elements G01N33/54386; involving labelled immunochemicals G01N33/58; for haemoglobin or occult blood G01N33/72

Abstract

A device and method are disclosed for use in the conduct of a non-invasive analysis of a bodily fluid to determine the presence and level of a certain constituent carried by the bodily fluid, which analysis utilizes an indicator formulation that changes color in response to exposure to the constituent to provide a visible indication of the presence and level of the constituent carried by the bodily fluid. A stabilizing formulation is carried in a vessel for mixing with a sample of the bodily fluid to be analyzed. The stabilizing formulation includes a first component for promoting formation of a film, a second component for adjusting the pH of the sample and inhibiting microbial digestion of the certain constituent carried by the bodily fluid, and a third component for reducing interference of ascorbic acid present in the bodily fluid. Where the certain constituent is glucose, the stabilizing formulation includes a microbial digestion inhibitor.

Claims

1. A method for use in the conduct of a non-invasive analysis of a bodily fluid to determine the presence and the level of a certain constituent carried by the bodily fluid, in which analysis a sample of the bodily fluid is exposed to an indicator formulation capable of changing color in response to exposure to the certain constituent provides a visible indication of the presence and the level of the certain constituent carried by the bodily fluid, the method comprising:

providing a vessel having a receptacle for receiving the sample of the bodily fluid;

providing a receptor construct within the vessel in juxtaposition with the receptacle;

providing a stabilizer formulation carried by the receptor construct in position to be exposed to the sample of the bodily fluid upon introduction of the sample into the receptacle;

the stabilizer formulation consisting essentially of;

a first component for promoting formation of a film;

a second component for adjusting the pH of the sample and inhibiting microbial digestion of the certain constituent carried by the bodily fluid; and

a third component for reducing interference of ascorbic acid present in the bodily fluid;

introducing the sample into the receptacle of the vessel prior to exposure of the sample to the indicator formulation; and

mixing the sample with the stabilizer formulation retained upon the receptor construct to prepare a mixture of the sample and the stabilizer formulation prior to exposure of the mixture to the indicator formulation and subsequent conduct of the non-invasive analysis.

2. The method of claim 1 including:

agitating the sample and the stabilizing formulation in the receptacle of the vessel; and

sealing the receptacle subsequent to placement of the sample and the stabilizing formulation within the receptacle so as to militate against escape of the sample and the stabilizing formulation while the vessel is agitated to mix the stabilizing formulation with the sample.

3. The method of claim 1 wherein the first component is PVP-K15.

4. The method of claim 1 wherein the second component is benzoic acid.

5. The method of claim 1 wherein the third component is ascorbate oxidase.

6. The method of claim 1 wherein the certain constituent is glucose, and the stabilizing formulation includes a further microbial digestion inhibitor.

7. The method of claim 6 wherein the further microbial digestion inhibitor is sodium fluoride.